Bibliographic Source(s)
Durbin DR, Committee on Injury, Violence, and Poison Prevention. Child passenger safety. Pediatrics 2011 Apr;127(4):e1050-66. [131 references] PubMed |
Guideline Status
This is the current release of the guideline.
All policy statements from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.
UMLS Concepts ( what's this?)
Click to view all guideline(s) indexed with these concepts
Hide...
|
Disease/Condition(s)
Motor vehicle-related injuries
Guideline Category
Counseling
Prevention
Clinical Specialty
Family Practice
Pediatrics
Intended Users
Physicians
Guideline Objective(s)
- To provide a summary of the evidence in support of 5 recommendations for best practices to optimize safety in passenger vehicles for children from birth through adolescence that all pediatricians should know and promote in their routine practice
- To provide pediatricians with a number of resources for additional information to use when providing anticipatory guidance to families
Target Population
Children from birth through adolescence and their families
Interventions and Practices Considered
- Age appropriate use and installation of child restraints
- Rear-facing child safety seat (CSS)
- Forward-facing CSS
- Belt-positioning booster seats
- Lap-and-shoulder seat belts
- Exposure to air bags
- Special considerations
- Safety of children left in or around vehicles
- Safety of children in pick-up trucks
- Safety of children on commercial airlines
Major Outcomes Considered
- Motor vehicle traffic-related injuries and fatalities
- Reported use of child restraint systems
- Effectiveness of car safety seats
|
Methods Used to Collect/Select the Evidence
Searches of Electronic Databases
Description of Methods Used to Collect/Select the Evidence
A search was performed in May 2009 using Medline via the OVID Database. The search included articles from all available years, with the exception of 3 search terms for which results were limited to the past 10 years. Results were limited to articles in English only, published in peer-reviewed journals. Search terms included the following:
- Motor vehicle accidents
- Motor vehicle crashes
- Child passenger safety
- Booster seats
- Child safety seats
- Car seats
- Racial disparities (cross-referenced with other terms)
- Seat belt syndrome*
- Seat belts and children*
- Children and air bags*
- Children, safety, and airplanes
- Child restraint laws
*Results limited to the past 10 years.
Number of Source Documents
Methods Used to Assess the Quality and Strength of the Evidence
Not stated
Rating Scheme for the Strength of the Evidence
Methods Used to Analyze the Evidence
Review
Description of the Methods Used to Analyze the Evidence
Methods Used to Formulate the Recommendations
Not stated
Rating Scheme for the Strength of the Recommendations
Cost Analysis
A formal cost analysis was not performed and published cost analyses were not reviewed.
Method of Guideline Validation
Not stated
Description of Method of Guideline Validation
|
Major Recommendations
Best-Practice Recommendations
- All infants and toddlers should ride in a rear-facing car safety seat (CSS) until they are 2 years of age or until they reach the highest weight or height allowed by the manufacturer of their CSS.
- All children 2 years or older, or those younger than 2 years who have outgrown the rear-facing weight or height limit for their CSS, should use a forward-facing CSS with a harness for as long as possible, up to the highest weight or height allowed by the manufacturer of their CSS.
- All children whose weight or height is above the forward-facing limit for their CSS should use a belt-positioning booster seat until the vehicle lap-and-shoulder seat belt fits properly, typically when they have reached 4 feet 9 inches in height and are between 8 and 12 years of age.
- When children are old enough and large enough to use the vehicle seat belt alone, they should always use lap-and-shoulder seat belts for optimal protection.
- All children younger than 13 years should be restrained in the rear seats of vehicles for optimal protection.
Clinical Algorithm(s)
An algorithm to guide the implementation of best-practice recommendations for optimal child passenger safety is provided in the Policy Statement (see the "Availability of Companion Documents" field).
|
Evidence Supporting the Recommendations
Type of Evidence Supporting the Recommendations
The type of evidence supporting the recommendations is not specifically stated.
|
Benefits/Harms of Implementing the Guideline Recommendations
Potential Benefits
Optimal safety in passenger vehicles for all children, from birth through adolescence
|
Qualifying Statements
The guidance in this report does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.
|
Implementation of the Guideline
Description of Implementation Strategy
Pediatricians play a critical role in promoting child passenger safety. To facilitate their widespread implementation in practice, evidence-based recommendations for optimal protection of children of all ages in passenger vehicles are presented in the form of an algorithm (Fig 1 in the Policy Statement [see the "Availability of Companion Documents" field]) with an accompanying table of explanations and definitions.
Because pediatricians are a trusted source of information to parents, every pediatrician must maintain a basic level of knowledge of these best-practice recommendations and promote and document them at every health-supervision visit. Prevention of motor vehicle crash injury is unique in health-supervision topics, because it is the only topic recommended at every health-supervision visit by Bright Futures. Pediatricians can also use this information to promote child passenger safety public education, legislation, and regulation at local, state, and national levels through a variety of advocacy activities, including ensuring that their state's child passenger safety law is in better alignment with the best-practice recommendations promoted in this policy statement. Because motor vehicle safety for children is multifaceted and will continue to evolve, all pediatricians should familiarize themselves with additional resources to address unique situations for their patients that may not be covered by the algorithm and to maintain current knowledge. In particular, many communities have child passenger safety technicians who have completed a standardized National Highway Traffic Safety Administration (NHTSA) course and who can provide hands-on advice and guidance to families. In most communities, child passenger safety technicians work at formal inspection stations; a list of these stations is available at www.seatcheck.org . If your community does not have an inspection station, you can find a child passenger safety technician in your area on the National Child Passenger Safety Certification Web site (http://cert.safekids.org ) or the NHTSA child safety seat inspection station locator (www.nhtsa.dot.gov/cps/cpsfitting/index.cfm ). Car seat checkup events are updated at www.safekidsweb.org/events/events.asp . In addition, additional resources for pediatricians and families can be found at www.aap.org or www.healthychildren.org .
Implementation Tools
Clinical Algorithm
Patient ResourcesFor information about availability, see the Availability of Companion Documents and Patient Resources fields below.
|
Institute of Medicine (IOM) National Healthcare Quality Report Categories
IOM Care Need
Staying Healthy
IOM Domain
Effectiveness
Patient-centeredness
Safety
|
Identifying Information and Availability
Bibliographic Source(s)
Durbin DR, Committee on Injury, Violence, and Poison Prevention. Child passenger safety. Pediatrics 2011 Apr;127(4):e1050-66. [131 references] PubMed |
Adaptation
Not applicable: The guideline was not adapted from another source.
Guideline Developer(s)
American Academy of Pediatrics - Medical Specialty Society
Source(s) of Funding
American Academy of Pediatrics
Guideline Committee
Committee on Injury, Violence, and Poison Prevention
Composition of Group That Authored the Guideline
Committee on Injury, Violence, and Poison Prevention, 2008-2010: H. Garry Gardner, MD, Chairperson; Carl R. Baum, MD; M. Denise Dowd, MD, MPH; Dennis R. Durbin, MD, MSCE, Lead Author; Beth E. Ebel, MD; Michele Burns Ewald, MD; Richard Lichenstein, MD; Mary Ann P. Limbos, MD; Joseph O'Neil, MD, MPH; Elizabeth C. Powell, MD; Kyran P. Quinlan, MD, MPH; Seth J. Scholer, MD, MPH; Robert D. Sege, MD, PhD; Michael S. Turner, MD; Jeffrey Weiss, MD
Contributor: Stuart Weinberg, MD – Partnership for Policy Implementation (PPI)
Liaisons: Julie Gilchrist, MD, Centers for Disease Control and Prevention; Lynne Janecek Haverkos, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Jonathan D. Midgett, PhD, Consumer Product Safety Commission; Alexander S. Sinclair, National Highway Traffic Safety Administration; Natalie L. Yanchar, MD, Canadian Paediatric Society
Staff: Bonnie Kozial
Financial Disclosures/Conflicts of Interest
All authors have filed conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process approved by the Board of Directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication.
Guideline Status
This is the current release of the guideline.
All policy statements from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.
Availability of Companion Documents
The following is available:
Patient Resources
The following is available:
Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.
NGC Status
This NGC summary was completed by ECRI Institute on August 3, 2011.
Copyright Statement
This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please contact the Permissions Editor, American Academy of Pediatrics (AAP), 141 Northwest Point Blvd, Elk Grove Village, IL 60007.
|
NGC Disclaimer
The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site. Read full disclaimer...The National Guideline Clearinghouseâ„¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.
All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.
Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion-criteria.aspx.
NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.
Readers with questions regarding guideline content are directed to contact the guideline developer. Hide...
|